Cargando…

Mouse models for BRCA1-associated breast cancer

Detalles Bibliográficos
Autores principales:	Wang, R-H, Li, W, Xu, X, Deng, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300123/ http://dx.doi.org/10.1186/bcr662

Ejemplares similares

BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype
por: Quinn, JE, et al.
Publicado: (2006)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
por: Ponder, B
Publicado: (2000)

Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications
por: Ponder, BAJ, et al.
Publicado: (2006)

Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?
por: Weber, BL
Publicado: (2000)

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2
por: West, SC, et al.
Publicado: (2006)

Imaging mouse models of breast cancer with positron emission tomography
por: Cherry, S, et al.
Publicado: (2003)

New regulators of the BRCA1 response to genotoxic stress
por: Morris, JR, et al.
Publicado: (2010)

Mouse models of human breast cancer: evolution or convolution?
por: Green, JE
Publicado: (2003)

Genetically engineered mouse models of human breast cancer
por: Jensen, RA
Publicado: (2003)

Use of BRCA1 protein:protein interactions to classify cancer risk
por: Morris, JR, et al.
Publicado: (2008)

Reversibility and progression in conditional transgenic mouse models of breast cancer
por: Chodosh, LA, et al.
Publicado: (2003)

Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
por: White, DE, et al.
Publicado: (2003)

Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
por: Crépin, M, et al.
Publicado: (2003)

Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1
por: Petalcorin, MIR, et al.
Publicado: (2006)

Mouse models for pretesting of immunotherapeutic strategies for cancer patients
por: Burchell, JM, et al.
Publicado: (2003)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Preclinical mouse models for BRCA1-associated breast cancer
por: Drost, R M, et al.
Publicado: (2009)

Using genomic similarities and differences to interpret mouse models of human development and cancer
por: Stubbs, L, et al.
Publicado: (2003)

Preneoplasia in mouse models
por: Medina, D
Publicado: (2003)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer
por: Hay, T, et al.
Publicado: (2008)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model
por: Pise-Masison, Cynthia A, et al.
Publicado: (2015)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

The role of IL-17 in the development of arthritis in mouse models
por: Iwakura, Y, et al.
Publicado: (2003)

Experimental mouse model of tuberculous uveitis
por: Abhishek, Sudhanshu, et al.
Publicado: (2014)

Tracing cellular sources of pathogenic type I-interferon in the TREX1(-/-) mouse model of lupus like-disease
por: Peschke, K, et al.
Publicado: (2015)

A breast cancer progression model: the importance of three-dimensional tissue architecture and metalloproteinases
por: Bissell, MJ, et al.
Publicado: (2005)

Modeling breast cancer in the rat: a method to produce knockout rats
por: Gould, MN
Publicado: (2003)

Modeling TMJD pain in the laboratory mouse: role of TRP ion channels
por: Chen, Yong, et al.
Publicado: (2014)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

The use of bilateral whole breast ultrasound to identify multifocal disease in newly diagnosed breast cancer
por: Wilkinson, LS, et al.
Publicado: (2004)

The role of Xeloda in metastasic breast cancer
por: Cortés-Funes, H
Publicado: (2005)

Addition of metabolomics to the omics spectrum for cancer biomarker development– demonstration with the KrasG12D mouse model for pancreatic carcinoma
por: Laiakis, Evagelia C, et al.
Publicado: (2014)

A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations
por: An, Q, et al.
Publicado: (2010)

Potential mechanisms whereby estrogens induce breast cancer in women
por: Santen, RJ, et al.
Publicado: (2005)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

A5 A MOUSE MODEL TO UNRAVEL THE PATHOPHYSIOLOGICAL LINK BETWEEN CROHN’S DISEASE AND TYPE-2 DIABETES-ASSOCIATED METABOLIC DISORDERS
por: Mukherjee, T, et al.
Publicado: (2023)

Functional genomic approaches to breast cancer
por: Bernards, R
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_at46fig1rahosurtd9i4lgqihe